Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.75K Hold
15
﹤0.01% 1284
2025
Q4
$3.2K Buy
15
+1
+7% +$205 ﹤0.01% 837
2025
Q3
$2.81K Buy
14
+4
+40% +$789 ﹤0.01% 814
2025
Q2
$2.09K Sell
10
-6
-38% -$1.15K ﹤0.01% 836
2025
Q1
$2.9K Buy
16
+6
+60% +$1.15K ﹤0.01% 792
2024
Q4
$1.9K Sell
10
-7
-41% -$1.35K ﹤0.01% 873
2024
Q3
$3.09K Hold
17
﹤0.01% 820
2024
Q2
$2.69K Sell
17
-1
-6% -$160 ﹤0.01% 799
2024
Q1
$2.62K Hold
18
﹤0.01% 799
2023
Q4
$2.28K Hold
18
﹤0.01% 794
2023
Q3
$1.91K Sell
18
-1
-5% -$111 ﹤0.01% 773
2023
Q2
$2.08K Hold
19
﹤0.01% 781
2023
Q1
$1.92K Buy
19
+6
+46% +$613 ﹤0.01% 786
2022
Q4
$1.3K Sell
13
-6
-32% -$573 ﹤0.01% 778
2022
Q3
$2K Sell
19
-1
-5% -$88 ﹤0.01% 775
2022
Q2
$2K Sell
20
-2
-9% -$178 ﹤0.01% 752
2022
Q1
$2K Hold
22
﹤0.01% 740
2021
Q4
$2K Hold
22
﹤0.01% 737
2021
Q3
$2K Sell
22
-2
-8% -$172 ﹤0.01% 738
2021
Q2
$2K Hold
24
﹤0.01% 722
2021
Q1
$2K Hold
24
﹤0.01% 695
2020
Q4
$2K Hold
24
﹤0.01% 635
2020
Q3
$1K Hold
24
﹤0.01% 651
2020
Q2
$1K Buy
24
+1
+4% +$57 ﹤0.01% 650
2020
Q1
$1K Sell
23
-1
-4% -$69 ﹤0.01% 645
2019
Q4
$2K Buy
24
+1
+4% +$74 ﹤0.01% 581
2019
Q3
$2K Sell
23
-11
-32% -$782 ﹤0.01% 568
2019
Q2
$3K Hold
34
﹤0.01% 543
2019
Q1
$3K Buy
+34
New +$2.45K ﹤0.01% 543

Other funds holding WAB

McIlrath & Eck's WAB Position: Q1 2026 in Review

McIlrath & Eck held its Wabtec (WAB) position steady in Q1 2026 at 15 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1284.

McIlrath & Eck first reported a position in WAB in Q1 2019 and has held it in 29 quarters since. 1,163 funds tracked by Wall St. Rank hold WAB as of Q1 2026.

  • McIlrath & Eck held 15 shares of Wabtec worth $3.75K as of Q1 2026.
  • McIlrath & Eck left its Wabtec share count unchanged in Q1 2026.
  • Wabtec made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1284 holding.
  • McIlrath & Eck first reported a position in Wabtec in Q1 2019 and has held it in 29 quarters since.
  • 1,163 funds tracked by Wall St. Rank held Wabtec as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.